Case of complete response to everolimus for metastatic renal cell carcinoma

Int J Urol. 2012 Sep;19(9):891-2. doi: 10.1111/j.1442-2042.2012.03039.x. Epub 2012 May 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abdominal Cavity
  • Acute Kidney Injury / chemically induced
  • Axitinib
  • Carcinoma, Renal Cell* / pathology
  • Carcinoma, Renal Cell* / therapy
  • Combined Modality Therapy
  • Everolimus
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Indazoles / administration & dosage
  • Indazoles / adverse effects
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / therapy
  • Lymph Node Excision* / adverse effects
  • Lymph Node Excision* / methods
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Nephrectomy / methods*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects
  • Remission Induction
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives*
  • Tomography, X-Ray Computed
  • Withholding Treatment

Substances

  • Imidazoles
  • Immunosuppressive Agents
  • Indazoles
  • Interferon-alpha
  • Protein Kinase Inhibitors
  • Everolimus
  • Axitinib
  • Sirolimus